AU2002360815A1 - Human breast cancer biomarkers - Google Patents

Human breast cancer biomarkers

Info

Publication number
AU2002360815A1
AU2002360815A1 AU2002360815A AU2002360815A AU2002360815A1 AU 2002360815 A1 AU2002360815 A1 AU 2002360815A1 AU 2002360815 A AU2002360815 A AU 2002360815A AU 2002360815 A AU2002360815 A AU 2002360815A AU 2002360815 A1 AU2002360815 A1 AU 2002360815A1
Authority
AU
Australia
Prior art keywords
breast cancer
human breast
cancer biomarkers
biomarkers
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002360815A
Other versions
AU2002360815A8 (en
Inventor
Christine Yip
Tai-Tung Yip
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aspira Womens Health Inc
Original Assignee
Ciphergen Biosystems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciphergen Biosystems Inc filed Critical Ciphergen Biosystems Inc
Publication of AU2002360815A8 publication Critical patent/AU2002360815A8/en
Publication of AU2002360815A1 publication Critical patent/AU2002360815A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
AU2002360815A 2001-12-27 2002-12-23 Human breast cancer biomarkers Abandoned AU2002360815A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34390701P 2001-12-27 2001-12-27
US60/343,907 2001-12-27
PCT/US2002/041614 WO2003058198A2 (en) 2001-12-27 2002-12-23 Human breast cancer biomarkers

Publications (2)

Publication Number Publication Date
AU2002360815A8 AU2002360815A8 (en) 2003-07-24
AU2002360815A1 true AU2002360815A1 (en) 2003-07-24

Family

ID=23348190

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002360815A Abandoned AU2002360815A1 (en) 2001-12-27 2002-12-23 Human breast cancer biomarkers

Country Status (2)

Country Link
AU (1) AU2002360815A1 (en)
WO (1) WO2003058198A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7041453B2 (en) 2002-08-22 2006-05-09 Bioarray Solutions Ltd. Molecular constructs and methods of use for detection of biochemical reactions
US7425700B2 (en) 2003-05-22 2008-09-16 Stults John T Systems and methods for discovery and analysis of markers
EP1896855A2 (en) * 2005-06-21 2008-03-12 Jean-Paul Borg Biomarkers for breast cancer
WO2012040447A2 (en) * 2010-09-22 2012-03-29 The Board Of Trustees Of The University Of Arkansas Biomarkers for determining breast cancer bone metastasis
CN117129704A (en) 2019-08-05 2023-11-28 禧尔公司 Systems and methods for sample preparation, data generation, and protein crown analysis

Also Published As

Publication number Publication date
AU2002360815A8 (en) 2003-07-24
WO2003058198A2 (en) 2003-07-17
WO2003058198A3 (en) 2004-10-14

Similar Documents

Publication Publication Date Title
AU2002360769A1 (en) Breast cancer expression profiling
IL251270A0 (en) Cancer treatment
AU2002212527A1 (en) Thermometry-based breast cancer risk assessment
AU2002362454A1 (en) Regulated breast cancer genes
AU2003214626A1 (en) Breast cancer screening
AU2002211835A1 (en) Oncology tissue microarrays
AUPS054702A0 (en) Cancer therapy
AU2003222604A1 (en) Proteins involved in breast cancer
AUPR395801A0 (en) Antibodies against cancer
AU2002220441A1 (en) Breast pump
GB0110847D0 (en) Breast cancer detection
AU2002258597A1 (en) Prognostic methods for breast cancer
AU2001288921A1 (en) Human breast cancer biomarkers
EP1380840A4 (en) Method of diagnosing breast cancer
AU2002360815A1 (en) Human breast cancer biomarkers
AU2002343714A1 (en) Breast cancer eradication program
AU2003283339A1 (en) Cancer therapy determination
AU2002249221A1 (en) Use of casb7439 (ash2) in the immunotherapy of breast cancer
AU2002358279A1 (en) Biomarkers for breast cancer
AU2002363807A1 (en) Breast cancer associated polypeptide
AU2002351382A1 (en) Combination cancer therapy
AU2002249475A1 (en) Breast cancer detection
AUPR645301A0 (en) Breast cancer detection
AU2001238697A1 (en) Personal breast cancer indicator
GB0122410D0 (en) Cancer diagnosis

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase